25 participants
Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Disease
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-09-01
- Start Date:
- 2024-12-18
- Completion:
- 2027-05-14
Conditions
- Sickle Cell Disease
- Hb-SS Disease
- Hemoglobin S
- Disease Sickle Cell Anemia
- Sickle Cell Disorders
- Hemoglobin Beta Thalassemia Disease
Interventions
- DRUG
No Results Yet